Tag: #LAGUNDI
-
DOST pushes for Lagundi as COVID-19 remedy
The Department of Science and Technology (DOST) expressed optimism that Lagundi (Chinese chaste tree) will soon be considered as a remedy to be used by patients with mild symptoms of coronavirus disease (COVID-19).
-
Data analysis on lagundi as COVID-19 therapeutic to be completed by end of June — DOST chief
The project team tasked to conduct clinical trials on the use of lagundi (Chinese chaste tree) as a coronavirus disease (COVID-19) therapeutic or supplement is expected to complete their data analysis “by end of this month.”
-
DOST: Initial data analysis results on VCO, lagundi as COVID-19 therapeutic expected by July
The “preliminary” results of the clinical trials on the use of the Virgin Coconut Oil (VCO), and lagundi (Chinese chaste tree) as a coronavirus disease (COVID-19) therapeutic or supplement could be expected by next month, an official of the Philippine Council for Health Research and Development (PCHRD) of the Department of Science and Technology (DOST-PCHRD) said on Sunday, June 27.
-
No serious adverse events observed in participants of PH’s clinical trials for lagundi as COVID-19 therapeutic —DOST
The condition of patients with mild coronavirus disease (COVID-19) who were involved in the country’s lagundi clinical trials has “not progressed” to moderate or severe cases, and no adverse effects have been observed in the participants, based on the study’s initial data analysis.
-
Data analysis for Stage 2 lagundi clinical trial to start next week – DOST chief
The Department of Science and Technology (DOST) has announced that the team tasked to look into the efficacy and safety of Laguna tablets or syrup as a coronavirus disease (COVID-19) therapeutic or supplement is set to conduct its data analysis for its placebo-controlled clinical trial next week.
-
VCO, lagundi, tawa-tawa clinical trials eyed to be completed by June – DOST
Clinical trials on the use of the Virgin Coconut Oil (VCO), lagundi (Chinese chaste tree), and tawa-tawa (Euphorbia hirta) as a coronavirus disease (COVID-19) therapeutic or supplement are expected to be completed by June, the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) said on Monday, May 3.